home / stock / vvos / vvos news

VVOS News and Press, Vivos Therapeutics Inc. From 03/25/21

Stock Information
Company Name: Vivos Therapeutics Inc.
Stock Symbol: VVOS
Market: NASDAQ
Website: vivoslife.com
Menu
VVOS VVOS Quote VVOS Short VVOS News VVOS Articles VVOS Message Board
Get VVOS Alerts

News, Short Squeeze, Breakout and More Instantly...
VVOS - Vivos Therapeutics EPS misses by $0.93, beats on revenue

Vivos Therapeutics (VVOS): FY GAAP EPS of -$1.40 misses by $0.93.Revenue of $13.07M (+14.7% Y/Y) beats by $0.13M.Shares +3.22%.Press Release For further details see: Vivos Therapeutics EPS misses by $0.93, beats on revenue

VVOS - Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update

Full Year Revenue Increase of 15% Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., March 25, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS) , a medical technology com...

VVOS - Vivos Therapeutics to Participate at the Benzinga Biotech Small Cap Conference

HIGHLANDS RANCH, Colo., March 22, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includi...

VVOS - How Wearables Sleep Tech Devices Are Offering Significant Relief For Insomniac Patients

Palm Beach, FL – March 18, 2021 – Sleep tech devices industry is progressing rapidly to bring accurate and compact solutions to deliver quality sleep. Moreover, increasing demand for portable and efficient sleep therapeutic devices is expected to offer lucrative growth opportu...
VVOS - Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5:00 pm ET

HIGHLANDS RANCH, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includi...

VVOS - Vivos Therapeutics to Participate at the Q1 Virtual Investor Summit

Vivos management to present at 1:30 pm Eastern Time on March 23, 2021 HIGHLANDS RANCH, Colo., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on develo...

VVOS - Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center

HIGHLANDS RANCH, Colo., March 08, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includi...
VVOS - Vivos Therapeutics to Participate in the Virtual 33rd Annual ROTH Conference on March 15-17, 2021

HIGHLANDS RANCH, Colo., March 01, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includi...

VVOS - Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults

HIGHLANDS RANCH, Colo., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includin...

VVOS - Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance

HIGHLANDS RANCH, Colo., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild ...
Previous 10 Next 10